Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226262 · ClinicalTrials.gov registry record
FFRangio Accuracy vs. Standard FFR
A clinical trial, sponsored by CathWorks.
- Completed
- Registry status
- 382
- Enrollment target
NCT03226262 is a clinical trial that has completed, run by CathWorks. The registered enrollment target is 382 participants.
The verdict
NCT03226262 has completed, sponsored by CathWorks.
- COMPLETED
- Registry status
- 382 participants
- Enrollment target
Study Summary
This is a prospective, observational, multi-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis.
Interventions
- DEVICE FFRangio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2017-09-27 |
| Est. Completion | 2018-06-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03226262
The ClinicalTrials.gov registry entry for NCT03226262 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 382 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CathWorks, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FFRangio is the first listed.
NCT03226262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03226262 about?
NCT03226262 is a clinical study titled "FFRangio Accuracy vs. Standard FFR". This is a prospective, observational, multi-center, single-arm, clinical trial designed to assess the efficacy of FFRangio in measuring FFR obtained from angiography compared to Invasive FFR for diagnosing hemodynamically significant coronary stenosis.
What is the current status of trial NCT03226262?
This trial is currently completed. The enrollment target is 382 participants. The study started on 2017-09-27. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT03226262?
The interventions under investigation include: FFRangio (DEVICE).
Who is sponsoring clinical trial NCT03226262?
This trial is sponsored by CathWorks, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.